English press releases

CTCL Global Care Collaborative Pioneers Consensus for Improving Diagnosis and Care in Cutaneous T-Cell Lymphoma (CTCL)

Patient advocacy groups form global collaborative to address unmet needs in CTCL, with support from Kyowa Kirin Consensus statement highlights 12 recommendations for healthcare authorities,...

SiPearl: Partnership with Samsung Electronics for built-in HBM in Rhea

SiPearl, the company building the high-performance low-power European microprocessor for HPC1 and AI inference, collaborates with Samsung Electronics, a world leader in advanced memory technology,...

KAYTUS Introduces the New K24V2 Multi-Node Server, Featuring Support for 8 High-Performance Processors in a 2U Form Factor

 Designed for Compute-Intensive Applications such as Automotive Collision Simulation, Weather Forecasting, and Biopharmaceutical Modeling, the K24V2 High-Density Multi-Node Server Delivers Industry-Leading High-Performance Computing Power in...

KAYTUS Released MotusAI, an AI Development Platform for Highly Efficient GPU Resource Scheduling and Task Orchestration

MotusAI Achieves an Average Cluster Computing Power Utilization Rate of Over 70% by Implementing Efficient and Unified GPU Scheduling SINGAPORE & HAMBURG, Germany–(BUSINESS WIRE)– KAYTUS,...

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

− Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression...

EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member

PARIS–(BUSINESS WIRE)– EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced...

The Ministry of Investment of Saudi Arabia (MISA) Signs MoU with Ant International to Expand Business in Saudi Arabia, Supporting Regional Digital Innovation

The Ministry of Investment of Saudi Arabia (MISA) has signed a Memorandum of Understanding (MoU) with Ant International to welcome and facilitate its business expansion...

The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences’ Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer Patients

LONDON–(BUSINESS WIRE)– Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK’s National Institute for Health and Care Excellence...

Rimini Street Earns Four 2024 Top Rated Awards from TrustRadius in the Services Category

Rimini Street selected as winner based entirely on excellent customer reviews in Implementation Services, Consulting and Advisory Services, IT Professional Services, and Managed IT Services...

Seven Additional Private Sector Leaders Announce Support for Antimicrobial Use Stewardship Principles in Poultry, Now Includes Over 40% of Global Poultry Meat Production

USAID-funded TRANSFORM project has united 26 organizations in antimicrobial use stewardship in an effort to combat antimicrobial resistance MINNEAPOLIS–(BUSINESS WIRE)– Antimicrobial use in animals or...

H.I.G. Realty Invests in Last-Mile Logistics and Industrial Outdoor Storage (“IOS”) Near Stansted Airport – London

LONDON–(BUSINESS WIRE)– H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $61 billion of capital under management, is pleased to announce that an affiliate...

QVC Signs Multi-Year Contract Extensions with SES in Germany and the UK

Worldwide leader in video commerce extends long-standing partnership to continue broadcasting multiple HD and SD channels from SES’s prime 19.2 degrees East and 28.2/28.5 degrees...

Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries

Galderma has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic dermatitis in...

IFF Reports First Quarter 2024 Results

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2024. Management Commentary “We have started the year well,...

IFF Chief Financial and Business Transformation Officer Glenn Richter to retire year end 2024

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF) today announced that Glenn Richter, IFF’s Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after...